BIO-FD&C CO.,LTD. Logo

BIO-FD&C CO.,LTD.

Develops plant cell-derived active ingredients for food, drug, and cosmetic industries.

251120 | KO

Overview

Corporate Details

ISIN(s):
KR7251120002
LEI:
Country:
South Korea
Address:
인천광역시 연수구 송도미래로 30 A동 509호, 510호, 511호, 인천광역시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

BIO-FD&C CO.,LTD. is a biotechnology company specializing in a proprietary plant cell platform technology to develop and commercialize materials for the food, drug, and cosmetic industries. Founded in 2005, the company leverages sustainable plant cell culture techniques to produce high-value active ingredients, including bioactive substances, recombinant proteins, and anti-aging compounds. Its core technological capabilities include the SMART-RC2 platform for enhancing metabolite production, radiofrequency-responsive protein expression, and extensive plant cell banking with over 250 cell lines. Supported by a significant portfolio of patents and scientific publications, BIO-FD&C is focused on providing innovative, plant-derived solutions to improve human health and develop future therapeutics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-10 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 121.7 KB
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.3 MB
2025-07-18 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 121.8 KB
2025-07-10 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 121.6 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.3 MB
2025-04-24 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-04-24 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 124.1 KB
2025-04-22 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 30.1 KB
2025-04-22 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 129.7 KB
2025-04-14 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 122.3 KB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 18.6 KB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 18.0 KB
2025-03-21 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 487.6 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 96.3 KB
2025-02-26 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 7.8 KB

Automate Your Workflow. Get a real-time feed of all BIO-FD&C CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIO-FD&C CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIO-FD&C CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Nuvectis Pharma, Inc. Logo
Clinical-stage biopharma developing precision medicines for serious oncological conditions.
United States of America
NVCT
Nykode Therapeutics ASA Logo
Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.
Norway
NYKD
Ocugen, Inc. Logo
Develops gene/cell therapies and vaccines, specializing in blindness and public health.
United States of America
OCGN
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.
Switzerland
OCS
OKYO Pharma Ltd Logo
Biopharma developing novel drugs for inflammatory eye diseases and neuropathic corneal pain.
United States of America
OKYO
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea
244460
A technology platform for pharma/biotech to discover therapeutic antibodies via transgenic animals.
United States of America
OABIW
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea
382150
Onconic Therapeutics Inc. Logo
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
South Korea
476060
OncoTherapy Science, Inc. Logo
Develops targeted cancer therapies and provides TCR repertoire analysis services.
Japan
4564

Talk to a Data Expert

Have a question? We'll get back to you promptly.